BioRestorative Therapies, Inc. financial data

Symbol
BRTX on Nasdaq
Location
40 Marcus Drive, Melville, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % -38.6%
Debt-to-equity 54.8 % +75.2%
Return On Equity -233 % -174%
Return On Assets -138 % -119%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.88M shares +28.3%
Common Stock, Shares, Outstanding 7.98M shares +15.3%
Entity Public Float 11.5M USD -16.1%
Common Stock, Value, Issued 797 USD +15.2%
Weighted Average Number of Shares Outstanding, Basic 9.12M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 9.12M shares +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 383K USD +1.7%
Research and Development Expense 7.92M USD +56.6%
General and Administrative Expense 6.95M USD -5.83%
Operating Income (Loss) -14.5M USD -20.1%
Nonoperating Income (Expense) 1.84M USD -24.5%
Net Income (Loss) Attributable to Parent -12.7M USD -31.3%
Earnings Per Share, Basic -1 USD/shares -37.4%
Earnings Per Share, Diluted -1 USD/shares -250%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 602K USD -59.6%
Marketable Securities, Current 3.89M USD -66.5%
Accounts Receivable, after Allowance for Credit Loss, Current 13.4K USD -91.9%
Assets, Current 4.71M USD -65.2%
Property, Plant and Equipment, Net 309K USD -18.2%
Operating Lease, Right-of-Use Asset 39.7K USD -74.3%
Intangible Assets, Net (Excluding Goodwill) 557K USD -13.9%
Assets 5.64M USD -61.3%
Accounts Payable, Current 860K USD +114%
Employee-related Liabilities, Current 539K USD
Accrued Liabilities, Current 744K USD +4.61%
Contract with Customer, Liability, Current 150K USD
Liabilities, Current 3.44M USD -25%
Operating Lease, Liability, Noncurrent 42.4K USD -78.7%
Liabilities 3.67M USD -31%
Retained Earnings (Accumulated Deficit) -167M USD -8.23%
Stockholders' Equity Attributable to Parent 2.21M USD -77.9%
Liabilities and Equity 5.64M USD -61.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.78M USD -19.9%
Net Cash Provided by (Used in) Financing Activities 1.09M USD -85.5%
Net Cash Provided by (Used in) Investing Activities 2.37M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 7.98M shares +15.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 681K USD +150%
Deferred Tax Assets, Valuation Allowance 29.4M USD -7.56%
Deferred Tax Assets, Gross 29.7M USD -7.5%
Operating Lease, Liability 42.4K USD -78.7%
Payments to Acquire Property, Plant, and Equipment 36.4K USD
Lessee, Operating Lease, Liability, to be Paid 43.3K USD -79.9%
Property, Plant and Equipment, Gross 1.47M USD +7.76%
Operating Lease, Liability, Current 42.4K USD -72.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 173K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 851 USD -94.8%
Deferred Tax Assets, Operating Loss Carryforwards 18M USD +25.8%
Preferred Stock, Shares Authorized 20M shares 0%
Operating Lease, Payments 43.3K USD +3%
Additional Paid in Capital 169M USD +2.98%
Amortization of Intangible Assets 22.4K USD +20.4%
Depreciation, Depletion and Amortization 39.4K USD +51.3%
Share-based Payment Arrangement, Expense 3.05M USD -24.8%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%